"Our award-winning cancer center is here to guide you from your first appointment through treatment and recovery. At Frauenshuh, we can offer you an appointment with an oncologist within 48 hours of a diagnosis. And our unique approach means you receive all your care in your treatment room. Without rushing between different locations for your cancer treatment. We'll help you find answers and get the unique treatment you need, including access to advanced clinical trials. Call today to make an appointment."

During the past decade, Park Nicollet Cancer Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 104 clinical trials were completed, i.e. on average, 866.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 16 clinical trials were completed. i.e. 320% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Park Nicollet Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 63 trials, followed by "Eastern Cooperative Oncology Group" with 23 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Park Nicollet Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 129 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Park Nicollet Cancer Center" are "Breast Cancer" (30 trials), "Lung Cancer" (17 trials), "Lymphoma" (14 trials), "Colorectal Cancer" (11 trials) and "Leukemia" (11 trials). Many other conditions were trialed in "Park Nicollet Cancer Center" in a lesser frequency.

Most popular intervention types in "Park Nicollet Cancer Center" are "Drug" (125 trials), "Biological" (54 trials), "Other" (45 trials), "Radiation" (28 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (26 trials), "bevacizumab" (15 trials), "cyclophosphamide" (15 trials), "carboplatin" (13 trials) and "radiation therapy" (13 trials). Other intervention names were less common.

The vast majority of trials in "Park Nicollet Cancer Center" are 122 trials for "All" genders, 25 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Park Nicollet Cancer Center". undefined are not yet recruiting, 4 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 108 completed trials in Park Nicollet Cancer Center, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Park Nicollet Cancer Center, 8 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".